Supplementary Table S5 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma

<p>Summary statistics for nucleosome footprints at YES1 and IGF1R regulatory motifs</p>

保存先:

書誌詳細
第一著者:	Srivandana Akshintala (16610490) (author)
その他の著者:	R. Taylor Sundby (15049851) (author), Donna Bernstein (16610493) (author), John W. Glod (16610496) (author), Rosandra N. Kaplan (16610499) (author), Marielle E. Yohe (15046970) (author), Andrea M. Gross (15086392) (author), Joanne Derdak (16610502) (author), Haiyan Lei (14963261) (author), Alexander Pan (16610505) (author), Eva Dombi (14942359) (author), Isabel Palacio-Yance (16610508) (author), Kailey R. Herrera (16610511) (author), Markku M. Miettinen (16610514) (author), Helen X. Chen (15030084) (author), Seth M. Steinberg (15043179) (author), Lee J. Helman (15049914) (author), Leo Mascarenhas (16610517) (author), Brigitte C. Widemann (15053620) (author), Fariba Navid (16610520) (author), Jack F. Shern (14938001) (author), Christine M. Heske (16610523) (author)
出版事項:	2025
主題:	Cancer Therapeutic Research and Development Clinical Research and Trials Methods and Technology Clinical Trial Results Clinical trials in pediatric cancer Phase I clinical trials Drug Targets Cell surface receptor drug targets Protein kinase & phosphatase drug targets Liquid Biopsy Pediatric Cancers Sarcomas Soft-tissue sarcoma
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料